SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-22-027287
Filing Date
2022-08-01
Accepted
2022-08-01 17:30:02
Documents
6
Effectiveness Date
2022-08-01

Document Format Files

Seq Description Document Type Size
1 S-8 maia-s8.htm S-8 116538
2 EX-5.1 maia-ex51_37.htm EX-5.1 11623
3 EX-23.1 maia-ex231_157.htm EX-23.1 3488
4 EX-99.3 maia-ex993_36.htm EX-99.3 180556
5 EX-FILING FEES maia-exfilingfees_38.htm EX-FILING FEES 135408
6 GRAPHIC g14vwzuzytiz000001.jpg GRAPHIC 11967
  Complete submission text file 0001564590-22-027287.txt   465242
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-266453 | Film No.: 221125997
SIC: 2834 Pharmaceutical Preparations